1. Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy. (11th October 2022) Authors: Nakamura, Naokazu; Arai, Yasuyuki; Kitawaki, Toshio; Jo, Tomoyasu; Mizumoto, Chisaki; Kanda, Junya; Nishikori, Momoko; Yamashita, Kouhei; Takaori‐Kondo, Akifumi Journal: British journal of haematology Issue: Volume 200:Number 1(2023) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Expression of Tim‐1 in primary CNS lymphoma. (5th October 2016) Authors: Kishimoto, Wataru; Nishikori, Momoko; Arima, Hiroshi; Miyoshi, Hiroaki; Sasaki, Yuya; Kitawaki, Toshio; Shirakawa, Kotaro; Kato, Takeharu; Imaizumi, Yoshitaka; Ishikawa, Takayuki; Ohno, Hitoshi; Haga, Hironori; Ohshima, Koichi; Takaori‐Kondo, Akifumi Journal: Cancer medicine Issue: Volume 5:Number 11(2016:Nov.) Page Start: 3235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas. (March 2020) Authors: Otsuka, Yasuyuki; Nishikori, Momoko; Arima, Hiroshi; Izumi, Kiyotaka; Kitawaki, Toshio; Hishizawa, Masakatsu; Takaori-Kondo, Akifumi Journal: Molecular immunology Issue: Volume 119(2020:Mar.) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Next‐generation sequencing in two cases of de novo acute basophilic leukaemia. Issue 14 (16th June 2021) Authors: Shimizu, Takuya; Kondo, Tadakazu; Nannya, Yasuhito; Watanabe, Mizuki; Kitawaki, Toshio; Shindo, Takero; Hishizawa, Masakatsu; Yamashita, Kouhei; Ogawa, Seishi; Takaori‐Kondo, Akifumi Journal: Journal of cellular and molecular medicine Issue: Volume 25:Issue 14(2021) Page Start: 7095 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Programmed cell death 1‐expressing CD56‐negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment. Issue 2 (16th December 2020) Authors: Ishiyama, Ken‐ichi; Kitawaki, Toshio; Otsuka, Yasuyuki; Takaori‐Kondo, Akifumi; Kadowaki, Norimitsu Journal: Cancer science Issue: Volume 112:Issue 2(2021) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B‐cell lymphoma and enhances T‐cell recruitment. Issue 11 (9th September 2021) Authors: Yuan, Hepei; Nishikori, Momoko; Otsuka, Yasuyuki; Arima, Hiroshi; Kitawaki, Toshio; Takaori‐Kondo, Akifumi Journal: Cancer science Issue: Volume 112:Issue 11(2021) Page Start: 4604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA. Issue 1 (6th December 2012) Authors: Fujita, Haruyuki; Kitawaki, Toshio; Sato, Takayuki; Maeda, Takahiro; Kamihira, Shimeru; Takaori‐Kondo, Akifumi; Kadowaki, Norimitsu Journal: European journal of immunology Issue: Volume 43:Issue 1(2013:Jan.) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial. Issue 3 (March 2020) Authors: Kimura, Shinya; Imagawa, Jun; Murai, Kazunori; Hino, Masayuki; Kitawaki, Toshio; Okada, Masaya; Tanaka, Hideo; Shindo, Motohiro; Kumagai, Takashi; Ikezoe, Takayuki; Uoshima, Nobuhiko; Sato, Tsutomu; Watanabe, Reiko; Kowata, Shugo; Hayakawa, Masaya; Hosoki, Takaaki; Ikeda, Kazuhiko; Kobayashi, Tsu... Journal: Lancet Issue: Volume 7:Issue 3(2020) Page Start: e218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗